Comparison of sublingual and oral captopril in hypertension
- PMID: 3038422
- DOI: 10.3109/10641968709164229
Comparison of sublingual and oral captopril in hypertension
Abstract
The use of sublingual captopril has been recently suggested in hypertensive crisis on the assumption of a faster absorption and thus a more rapid effect on blood pressure than with the oral route. To verify this hypothesis we have compared the hypotensive effect of oral and sublingual captopril in 40 essential hypertensives who were randomly allocated to either route of administration. Captopril was administered orally dissolved in water or allowed to dissolve under the tongue. After 5, 10, 20, 30, 40, 60 and 90 minutes blood pressure, Plasma Renin Activity (PRA) and Angiotensin Converting Enzyme (ACE) were measured. No significant differences were found between the two groups in the time course of blood pressure decrease, PRA increase and ACE inhibition. The changes of the parameters studied was superimposable irrespective of the route of administration thus not supporting the hypothesis that sublingual captopril might be absorbed more rapidly.
Similar articles
-
A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.Int J Clin Pharmacol Ther Toxicol. 1983 Nov;21(11):569-74. Int J Clin Pharmacol Ther Toxicol. 1983. PMID: 6317579
-
Converting enzyme activity and essential hypertension.Klin Wochenschr. 1983 Apr 1;61(7):377-8. doi: 10.1007/BF01485031. Klin Wochenschr. 1983. PMID: 6306333
-
Comparison of sublingual captopril and sublingual nifedipine in hypertensive emergencies.Jpn J Pharmacol. 1990 Feb;52(2):189-93. doi: 10.1254/jjp.52.189. Jpn J Pharmacol. 1990. PMID: 2179605
-
Dose response in captopril therapy of hypertension.Clin Pharmacol Ther. 1980 Sep;28(3):310-5. doi: 10.1038/clpt.1980.167. Clin Pharmacol Ther. 1980. PMID: 6250759
-
Angiotensin I-converting enzyme gene polymorphism and acute response to captopril in essential hypertension.Am J Hypertens. 1997 Sep;10(9 Pt 1):1064-8. doi: 10.1016/s0895-7061(97)00279-3. Am J Hypertens. 1997. PMID: 9324115
Cited by
-
Clinical pharmacokinetics of drug administered buccally and sublingually.Clin Pharmacokinet. 1991 Aug;21(2):83-94. doi: 10.2165/00003088-199121020-00001. Clin Pharmacokinet. 1991. PMID: 1884569 Review. No abstract available.
-
A pharmacokinetic and pharmacodynamic evaluation of buffered sublingual captopril in patients with congestive heart failure.Eur J Clin Pharmacol. 1996;49(6):471-6. doi: 10.1007/BF00195933. Eur J Clin Pharmacol. 1996. PMID: 8706772 Clinical Trial.
-
Sublingual captopril--a pharmacokinetic and pharmacodynamic evaluation.Eur J Clin Pharmacol. 1991;40(4):393-8. doi: 10.1007/BF00265850. Eur J Clin Pharmacol. 1991. PMID: 2050174 Clinical Trial.
-
Prevention of recurrent autonomic dysreflexia: a survey of current practice.Clin Auton Res. 2015 Oct;25(5):293-300. doi: 10.1007/s10286-015-0303-0. Epub 2015 Aug 18. Clin Auton Res. 2015. PMID: 26280219
-
The effect of captopril on peripheral hemodynamics in patients with essential hypertension: comparison between oral and sublingual administration.Cardiovasc Drugs Ther. 1990 Jun;4(3):751-4. doi: 10.1007/BF01856565. Cardiovasc Drugs Ther. 1990. PMID: 2076385
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous